Objective: Post-viral olfactory disorder (PVOD) is a troublesome disorder. Only 29.6% of patient gained significant improvement after corticosteroid treatment. There have been few studies on alternative way in treating post-viral olfactory disorder (PVOD). The purpose of this case study was to investigate the effect of Bo’s abdominal acupuncture in a patient with PVOD. Case presentation: A 52-year-old female presented with hyposmia and parosmia for over one month. At first, she noticed loss of the sense of smell after recovery from the cold, and about one week later, all her sense of smell became garlic odor. Initially she visited otolaryngologist for help. Viral sinusitis was diagnosed though image studies showed no structural abnormality that would cause conductive olfactory dysfunction. Daily steroids was prescribed for four weeks, but her sense of smell was not improved. Therefore, she came to our department of acupuncture for help. Methods and outcome: According to the theories of Bo’s abdominal acupuncture, CV12 (Zhongwan, 中脘), CV10 (Xiawan, 下脘), CV6 (Qihai, 氣海), and CV4 (Guanyuan, 關元) were applied for conducting Qi back to its origin. Both sides of ST24, KI13, KI17, KI18, and KI19 were prescribed for symptoms of upper-jiao, especially located at head, therefore we chose them for olfactory dysfunction. Ab1 were applied for nasal diseases. SP15 was prescribed for strengthening the spleen and eliminating dampness. All acupoints mentioned above are the treatment protocol for common cold and nasal diseases. Disposable stainless steel filiform needles (30 gauges, 40mm long) were inserted and retained for 15 minutes. Acupuncture was performed twice a week for two months. During the course of treatment, her garlic smell faded away and she could recognize flavor of fruits and flowers over time. Conclusion:Abdominal acupuncture can improve the sense of smell and nasal symptoms of PVOD patients, without disadvantages of somatic acupuncture including painful sense and poor compliance. It might be a choice of alternative or adjuvant therapy for PVOD when patients were refractory to corticosteroids. However, the possibility of natural recovery could not be ruled out. We need more clinical cases and well-designed clinical trials to confirm the effectiveness.